Gastro meets Kardio » Faltblatt zur Veranstaltung herunterladen (PDF) 17. Februar 2021 Impfung und Covid-19 bei CED » Faltblatt zur Veranstaltung herunterladen (PDF) 3. Februar 2021 Corona-Impfung nach
C (2025). Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection. Front Immunol. 2025 Jan 6;15:1488745. doi: 10.3389/fimmu.2024.1488745. eCollection 2024
the time - the Medical School Hannover. He guided MHH through truly turbulent times, including the COVID-19 pandemic and the planning of a complete rebuild of a university hospital, among other challenges
Schindler C (2025, eingereicht) „Ethical concerns of challenge studies in a pandemic: lessons from COVID-19“. In: Mitrović V, Kühler M, Gordijn B (Hrsg) Enhancing Resilience and Preparedness in Future Pandemics:
J, Schäfers J, Geyer S, Haier J, Epping J (2022). Patterns of Changes in Oncological Care due to COVID-19: Results of a Survey of Oncological Nurses and Physicians from the Region of Hanover, Germany. [...] 1159/000529708 Beller J, Schäfers J, Haier J, Geyer S, Epping J (2022) . Trust in Healthcare during COVID-19 in Europe: vulnerable groups trust the least. J Public Health (Berl.). https://doi.org/10.1007 [...] J, Schäfers J, Geyer S, Haier J, Epping J (2022). Patterns of Changes in Oncological Care due to COVID-19: Results of a Survey of Oncological Nurses and Physicians from the Region of Hanover, Germany.
Cornberg M, Koenecke C, Behrens GMN, Bošnjak B, Förster R. Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment [...] Koenecke, C., & Schultze-Florey, C. R. Reappearance of effector T cells is associated with recovery from COVID-19 [published online ahead of print, 2020 Jul 7]. EBioMedicine. 2020;57:102885. doi:10.1016/j.ebiom
10.1038/s41598-021-84468-3 Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. Ricke-Hoch M, Stelling E, Lasswitz L, Gunesch AP, Kasten M, Zapatero-Belinchon FJ, Brogden
guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due the COVID-19 pandemic. NPJ Breast Cancer 6:21. Kolberg-Liedtke C, Gluz O, Heinisch F, Feuerhake F, Kreipe H